摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

氟化苯磺酰,3-甲酰基-2,4,6-三甲基- | 139650-07-0

中文名称
氟化苯磺酰,3-甲酰基-2,4,6-三甲基-
中文别名
——
英文名称
3-Formyl-2,4,6-trimethylbenzenesulfonyl fluoride
英文别名
——
氟化苯磺酰,3-甲酰基-2,4,6-三甲基-化学式
CAS
139650-07-0
化学式
C10H11FO3S
mdl
——
分子量
230.26
InChiKey
DZFFZMKIBQYEON-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    333.6±42.0 °C(Predicted)
  • 密度:
    1.274±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    59.6
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    H2NO(CH2)CO-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]bombesin(6-14) 、 氟化苯磺酰,3-甲酰基-2,4,6-三甲基-二甲基亚砜 为溶剂, 反应 5.0h, 生成
    参考文献:
    名称:
    磺酰氟基义肢化合物作为潜在的18F标记剂
    摘要:
    的[亲核掺入18 F]˚F -含水条件下保持在放射性药物的开发若干优点,特别是复杂的生物药效的出现。磺酰氟可在室温下于水中制备,但尚未被检测为18 F标记的PET化学标记物的潜在手段。我们开发了一条通用路线,从乙腈,THF或叔丁基的1:1混合物中,由磺酰氯类似物制备双功能的4-甲酰基,3-甲酰基,4-马来酰亚胺基和4-氧炔基-芳基磺酰基[ 18 F]氟化物。BuOH和Cs [ 18 F] F / Cs 2 CO 3(水溶液)在室温下反应时间为15分钟。除4 - N-马来酰亚胺-苯磺酰氟(3)外,吡啶可用于选择性地降解前体而不会显着影响产率,从而简化放射性示踪剂的纯化。在[ 18 F]氟化开始时添加吡啶(1:1:0.8 t BuOH / Cs 2 CO 3(aq。) /吡啶)不会对3-甲酰基-2,4,6-三甲基苯磺酰基的收率产生负面影响[ 18 F]氟化物(2)并显着提高了4-(prop-2-ynyloxy)苯磺酰基[
    DOI:
    10.1002/chem.201103450
  • 作为产物:
    描述:
    参考文献:
    名称:
    磺酰氟基义肢化合物作为潜在的18F标记剂
    摘要:
    的[亲核掺入18 F]˚F -含水条件下保持在放射性药物的开发若干优点,特别是复杂的生物药效的出现。磺酰氟可在室温下于水中制备,但尚未被检测为18 F标记的PET化学标记物的潜在手段。我们开发了一条通用路线,从乙腈,THF或叔丁基的1:1混合物中,由磺酰氯类似物制备双功能的4-甲酰基,3-甲酰基,4-马来酰亚胺基和4-氧炔基-芳基磺酰基[ 18 F]氟化物。BuOH和Cs [ 18 F] F / Cs 2 CO 3(水溶液)在室温下反应时间为15分钟。除4 - N-马来酰亚胺-苯磺酰氟(3)外,吡啶可用于选择性地降解前体而不会显着影响产率,从而简化放射性示踪剂的纯化。在[ 18 F]氟化开始时添加吡啶(1:1:0.8 t BuOH / Cs 2 CO 3(aq。) /吡啶)不会对3-甲酰基-2,4,6-三甲基苯磺酰基的收率产生负面影响[ 18 F]氟化物(2)并显着提高了4-(prop-2-ynyloxy)苯磺酰基[
    DOI:
    10.1002/chem.201103450
点击查看最新优质反应信息

文献信息

  • Formylated alkylbenzenesulfonyl halide compound
    申请人:Agency of Industrial Science and Technology
    公开号:US05030752A1
    公开(公告)日:1991-07-09
    A formylated alkylbenzenesulfonyl halide compound represented by the following general formula (I): ##STR1## wherein R.sub.1 is an alkyl group having 1 to 5 carbon atoms; R.sub.2 and R.sub.3 are each a member selected from the group consisting of a hydrogen atom and alkyl groups having 1 to 5 carbon atoms; X is a halogen atom; the sulfonyl halide group is present at the ortho or para position while the formyl group at the para or ortho position relative to the group R.sub.1 when R.sub.2 and R.sub.3 are both a hydrogen atom, while the sulfonyl halide group and the formyl group are present at the para positions relative to the groups R.sub.1 and R.sub.2, respectively, when R.sub.2 is an alkyl group and R.sub.3 is a hydrogen atom, or the sulfonylhalide group and the formyl group are present at the para positions relative to the groups R.sub.1 and R.sub.2, respectively, when R.sub.2 and R.sub.3 are both an alkyl group; the compound (I) being prepared by reacting an alkylbenzene represented by the following formula (III) with carbon monoxide and a halosulfonic acid represented by the following formula (II) in the presence of an antimony halide: XSO.sub.3 H (II) ##STR2## wherein all of X in the formula (II) and R.sub.1, R.sub.2 and R.sub.3 in the formula (III) are as defined above.
    以下为通式(I)所代表的酰甲基化烷基苯磺酰卤化物化合物:##STR1## 其中,R1是具有1至5个碳原子的烷基基团;R2和R3分别是从氢原子和具有1至5个碳原子的烷基基团中选择的成员;X是卤素原子;当R2和R3均为氢原子时,磺酰卤基位于邻位或对位,而酰甲基位于对位或邻位相对于基团R1,而当R2是烷基基团而R3是氢原子时,磺酰卤基和酰甲基分别位于基团R1和R2的对位位置,而当R2和R3均为烷基基团时,磺酰卤基和酰甲基分别位于基团R1和R2的对位位置;化合物(I)通过在卤化物的存在下,将以下化学式(III)所代表的烷基苯和以下化学式(II)所代表的卤代磺酸一氧化碳反应制备而成:XSO3H(II)##STR2## 其中,化学式(II)中的X以及化学式(III)中的R1、R2和R3均如上定义。
  • Formylation of aromatic compounds with carbon monoxide in HSO3F-SbF5 uner atmospheric pressure
    作者:Mutsuo Tanaka、Jun Iyoda、Yoshie Souma
    DOI:10.1021/jo00035a024
    日期:1992.4
    The formylation of aromatic compounds such as benzene, toluene, xylenes, mesitylene, indan, tetralin, fluorobenzene, chlorobenzene, and bromobenzene was carried out in HSO3F-SbF5 under atmospheric CO pressure at 0-degrees-C. In HSO3F-SbF5, both formylation and sulfonation took place to give formyl and sulfonyl compounds. In the case of alkylbenzenes, including toluene, xylenes, mesitylene, and tetralin, formylalkylbenzenesulfonyl fluorides, new compounds, were obtained by a one-pot reaction as well as alkylbenzaldehydes, alkylbenzenesulfonyl fluorides, and bis(alkylphenyl) sulfones. The direct introduction of a formyl and sulfonyl group was achieved in alkylbenzenes. The reaction path of the new compounds is a two-step reaction comprised of formylation as the first step and sulfonation as the second step. The product composition was strongly dependent on the acid strength of the HSO3F-SbF5 systems. The formyl compounds became predominant with increasing acidity of the HSO3F-SbF5 system. On the other hand, only sulfonyl compounds were produced when the acidity of the HSO3F-SbF5 system was low.
  • Dual Reactivity of the Formyl Cation as an Electrophile and a Broensted Acid in Superacids
    作者:Matsuo Tanaka、Masahiro Fujiwara、Hisanori Ando
    DOI:10.1021/jo00117a041
    日期:1995.6
    The nature of the formyl cation in the Gattermann-Koch formylation was studied by comparing the formylation with the acetylation and sulfonation in CF3SO3H-SbF5 and FSO3H-SbF5, respectively. The results of the kinetic studies in CF3SO3H-SbF5 showed that the formyl cation has dual reactivity as an electrophile and as a Bronsted acid. Upon comparing the formylation with the sulfonation in FSO3H-SbF5, it was found that the protonated aromatic compounds also act as Bronsted acids to produce formyl cations. Therefore, the formylation has a priority over other typical electrophilic substitutions under conditions where most of aromatic compounds are protonated because the formyl cation is reproduced close to the aromatic compounds by the protonation of CO with not only superacids but also protonated aromatic compounds.
  • US5030752A
    申请人:——
    公开号:US5030752A
    公开(公告)日:1991-07-09
  • US5095150A
    申请人:——
    公开号:US5095150A
    公开(公告)日:1992-03-10
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫